ZeroStack
Stakes 0G tokens and distributes pharmaceuticals through its German Phatebo business.
Something off on this page? Send us feedback.
Profile
Combines 0G token staking, which generates validation rewards, with Phatebo's pharmaceutical distribution business. The asset base is concentrated in the 0G network, while commercial operations depend on product inventory financing.
Pairs a 0G token treasury and staking operation with Phatebo, a German pharmaceutical wholesaler. Phatebo imports and exports pharmaceutical and medical products, distributing primarily across Europe and also in Asia, Latin America, and North America; its sales form the commercial revenue base.
Earns digital-asset revenue from 0G validation rewards through a third-party validator, while maintaining control of its staked tokens. Management allocates capital between the two segments and may finance token purchases through equity or debt.
Depends on the 0G network's adoption, staking rules, limited custody and trading access, and evolving token, investment-company, and AI regulation. Phatebo's ability to fulfill its orders also depends on inventory financing.
Company facts
Categories
Key statistics
Year to date −18.5% · Average volume (30d) 940.3K
Analysts
Ratings
Target range
Latest analyst notes
No analyst notes in the last 24 months.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026Q2 FY26 | −$0.11 | −$2.47 | −2,145.5% | $7.3M | $13.7M | +87.1% | +13.82% |
| May 4, 2026Q1 FY26 | −$1.18 | −$3.68 | −211.9% | $13.1M | $7.3M | −44.5% | +2.62% |
| May 1, 2026Q1 FY26 | −$1.18 | −$3.68 | −211.9% | $13.1M | $7.3M | −44.5% | −4.24% |
| Mar 23, 2026Q4 FY25 | −$0.17 | −$35.32 | −20,725.5% | $15.3M | −$654.0K | −104.3% | −4.07% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $11.8M | $14.8M | $9.7M | $9.4M | $7.3M | $13.7M | |
| Gross profit | $2.9M | $2.8M | $335.0K | −$2.6M | −$594.0K | −$1.0M | |
| Operating income | −$977.0K | −$2.6M | −$3.3M | −$4.4M | −$1.2M | −$2.1M | |
| Net income | −$758.0K | −$2.4M | −$6.7M | −$109.9M | −$36.7M | −$24.6M | |
| Diluted EPS | −$1.54 | −$4.27 | −$9.05 | −$105.07 | −$3.68 | −$2.47 | |
| Gross margin | 24.5% | 19.1% | 3.4% | -27.9% | -8.2% | -7.6% | |
| Operating margin | -8.3% | -17.3% | -33.5% | -47.3% | -17.1% | -15.1% |
Fiscal years (4-quarter sums)FY21 $9.0M · FY22 $35.1M · FY23 $76.1M · FY24 $59.5M · FY25 $45.7M
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $3.0M · Total debt $2.8M · Total assets $25.2M · Shareholders' equity $13.8M
Dividends
No dividends on record.
Ownership
Shares outstanding 1.05M · Float 836.0K · 79.9% free float
Insiders — filings are in another share unit.
The Form 4 positions here total more than the shares outstanding, so the filings and the share count are not on the same basis — usually an unlisted unit behind the listed one — and no insider percentage is shown.
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Reis-Faria Daniel | 6.43M | 88.30% | 13D | Dec 23, 2025 |
| Heinrich Michael | 5.37M | 86.40% | 13D | Dec 23, 2025 |
| Vaiman Dany | 263.2K | 23.80% | 13D | Dec 23, 2025 |
| Vanguard Capital Management LLC | 25.4K | 2.43% | 13F | May 15, 2026 |
| Geode Capital Management, LLC | 25.3K | 2.42% | 13F | May 15, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 19, 2026 | Rudy Rong | officer: President | −1,000 | $7.57 |
| Jul 20, 2026 | Michael Heinrich | director, officer: Executive Chairman | +4,608,575 | $0.7549 |
| Oct 9, 2025 | Daniel Reis-Faria | director, officer: CEO | +5,954,743 | $0.0001 |
Peers
- Cencora
European pharmaceutical distribution overlap in supplier and pharmacy channels.
- DeFi Development
Solana treasury and validator model overlaps with 0G staking.
- Sharplink
Ethereum treasury and staking alternative for digital-asset investors.
- Strategy
Large public Bitcoin treasury benchmark for digital-asset capital.
- Interactive Strength
AI-token treasury alternative tied to Fetch.ai's agent ecosystem.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| ZeroStack | $5.50 | −1.43% | $5.8M | — | — | 0.1 | −7.7% |
| Cencora | $320.00 | −0.60% | $62.65B | 23.9 | 16.6 | 0.2 | +5.1% |
| DeFi Development | $4.91 | −1.21% | $150.0M | — | — | 9.9 | +66.9% |
| Sharplink | $8.19 | −0.18% | $1.62B | — | 196.9 | 32.2 | +1,553.3% |
| Strategy | $127.88 | +0.46% | $42.12B | — | 3.7 | 84.5 | +6.9% |
| Interactive Strength | $3.07 | +1.99% | $1.5M | — | — | 0.1 | +441.4% |
| Median | 23.9 | 16.6 | 9.9 | +66.9% |